The present article discusses the outcomes of two cases of endophthalmitis due …

• Abstract
• Background
• Case Presentation
• Conclusion
• References
• Figure

Biology Articles » Mycology » Treatment of two postoperative endophthalmitis cases due to Aspergillus flavus and Scopulariopsis spp. with local and systemic antifungal therapy » References

References

- Treatment of two postoperative endophthalmitis cases due to Aspergillus flavus and Scopulariopsis spp. with local and systemic antifungal therapy

1.   Read RW: Endophthalmitis.In Ophthalmology. 2nd edition. Edited by: Yanoff M. DJS. St Louis, Mosby Inc.; 2004:1152-1157.       2.   Benz MS, Scott IU, Flynn HW Jr., Unonius N, Miller D: Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases.Am J Ophthalmol 2004, 137:38-42.       3.   Kunimoto DY, Das T, Sharma S, Jalali S, Majji AB, Gopinathan U, Athmanathan S, Rao TN: Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis. Endophthalmitis Research Group.Am J Ophthalmol 1999, 128:240-242.       4.   Han DP, Wisniewski SR, Wilson LA, Barza M, Vine AK, Doft BH, Kelsey SF: Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study.Am J Ophthalmol 1996, 122:1-17.       5.   Anand AR, Therese KL, Madhavan HN: Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates.Indian J Ophthalmol 2000, 48:123-128.       6.   Kuriakose T, Kothari M, Paul P, Jacob P, Thomas R: Intracameral amphotericin B injection in the management of deep keratomycosis.Cornea 2002, 21:653-656.       7.   Hua G, Pennesi M, Shah K, Qiao X, Hariprasad SM, Mieler WF, Wu SM, Holz ER: Safety of intravitreal voriconazole: electroretinographic and histopathologic studies.Trans Am Ophthalmol Soc 2003, 101:183-9; discussion 189.       8.   Marangon FB, Miller D, Giaconi JA, Alfonso EC: In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.Am J Ophthalmol 2004, 137:820-825.       9.   Durand ML, Kim IK, D'Amico DJ, Loewenstein JI, Tobin EH, Kieval SJ, Martin SS, Azar DT, Miller FS 3rd, Lujan BJ, Miller JW: Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin.Am J Ophthalmol 2005, 140:552-554.       10.   Breit SM, Hariprasad SM, Mieler WF, Shah GK, Mills MD, Grand MG: Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.Am J Ophthalmol 2005, 139:135-140.       11.   Shrader SK, Band JD, Lauter CB, Murphy P: The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome.J Infect Dis 1990, 162:115-120.       12.   Kresloff MS, Castellarin AA, Zarbin MA: Endophthalmitis.Surv Ophthalmol 1998, 43:193-224.       13.   Jackson TL, Eykyn SJ, Graham EM, Stanford MR: Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases.Surv Ophthalmol 2003, 48:403-423.       14.   Binder MI, Chua J, Kaiser PK, Procop GW, Isada CM: Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center.Medicine (Baltimore) 2003, 82:97-105.       15.   Schiedler V, Scott IU, Flynn HW Jr., Davis JL, Benz MS, Miller D: Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes.Am J Ophthalmol 2004, 137:725-731.       16.   Narang S, Gupta A, Gupta V, Dogra MR, Ram J, Pandav SS, Chakrabarti A: Fungal endophthalmitis following cataract surgery: clinical presentation, microbiological spectrum, and outcome.Am J Ophthalmol 2001, 132:609-617.       17.   Pettit TH, Olson RJ, Foos RY, Martin WJ: Fungal endophthalmitis following intraocular lens implantation. A surgical epidemic.Arch Ophthalmol 1980, 98:1025-1039.       18.   Fridkin SK, Kremer FB, Bland LA, Padhye A, McNeil MM, Jarvis WR: Acremonium kiliense endophthalmitis that occurred after cataract extraction in an ambulatory surgical center and was traced to an environmental reservoir.Clin Infect Dis 1996, 22:222-227.       19.   Essman TF, Flynn HW Jr., Smiddy WE, Brod RD, Murray TG, Davis JL, Rubsamen PE: Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis.Ophthalmic Surg Lasers 1997, 28:185-194.       20.   Elder MJ, Morlet N: Endophthalmitis.Clin Experiment Ophthalmol 2002, 30:394-398.       21.   Riddell Iv J, McNeil SA, Johnson TM, Bradley SF, Kazanjian PH, Kauffman CA: Endogenous Aspergillus endophthalmitis: report of 3 cases and review of the literature.Medicine (Baltimore) 2002, 81:311-320.       22.   Tabbara KF, al Jabarti AL: Hospital construction-associated outbreak of ocular aspergillosis after cataract surgery.Ophthalmology 1998, 105:522-526.       23.   Gariano RF, Kalina RE: Posttraumatic fungal endophthalmitis resulting from Scopulariopsis brevicaulis.Retina 1997, 17:256-258.       24.   Pflugfelder SC, Flynn HW Jr., Zwickey TA, Forster RK, Tsiligianni A, Culbertson WW, Mandelbaum S: Exogenous fungal endophthalmitis.Ophthalmology 1988, 95:19-30.       25.   McMahon MM, Bistrian BR: Host defenses and susceptibility to infection in patients with diabetes mellitus.Infect Dis Clin North Am 1995, 9:1-9.       26.   Leibovici L, Yehezkelli Y, Porter A, Regev A, Krauze I, Harell D: Influence of diabetes mellitus and glycaemic control on the characteristics and outcome of common infections.       27.   Eschete ML, King JW, West BC, Oberle A: Penicillium chrysogenum endophthalmitis.Mycopathologia 1981, 74:125-127.       28.   Swan SK, Wagner RA, Myers JP, Cinelli AB: Mycotic endophthalmitis caused by Penicillium sp. after parenteral drug abuse.Am J Ophthalmol 1985, 100:408-410.       29.   Lyratzopoulos G, Ellis M, Nerringer R, Denning DW: Invasive infection due to penicillium species other than P. marneffei.J Infect 2002, 45:184-195.       30.   Galland F, le Goff L, Conrath J, Ridings B: [Penicillium chrysogenum endophthalmitis: a case report].J Fr Ophtalmol 2004, 27:264-266.       31.   Stevens DA, Kan VL, Judson MA, Morrison VA, Dummer S, Denning DW, Bennett JE, Walsh TJ, Patterson TF, Pankey GA: Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.Clin Infect Dis 2000, 30:696-709.       32.   Arikan S, Lozano-Chiu M, Paetznick V, Rex JH: In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.Antimicrob Agents Chemother 2002, 46:245-247.       33.   Cuenca-Estrella M: Combinations of antifungal agents in therapy--what value are they?J Antimicrob Chemother 2004, 54:854-869.